Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Aug 9:9:113.
doi: 10.1186/1477-7827-9-113.

A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis

Affiliations
Comparative Study

A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis

Alexandra Vodolazkaia et al. Reprod Biol Endocrinol. .

Abstract

Background: Endometriosis is associated with chronic subclinical inflammation. C-reactive protein (CRP), a marker of inflammation, could serve as a biomarker of endometriosis. We tested the hypothesis that a high sensitivity CRP assay (hsCRP) is more accurate than a classical CRP assay in the detection of subclinical inflammation in plasma of women with endometriosis.

Methods: CRP levels were measured by hsCRP and classical CRP assays in plasma of 204 women with endometriosis and 91 women without endometriosis. Both assays were compared with respect to their value for the diagnosis of endometriosis.

Results: The number of plasma samples with detectable CRP was significantly higher (100%) using the hsCRP assay when compared to the classical CRP assay (42.7%) (p < 0.0001). Significantly increased CRP plasma levels were found in women with endometriosis when compared with controls when the hsCRP assay was used in samples obtained during the luteal phase (p = 0.008). The highest discriminative ability for the diagnosis of endometriosis was also obtained using the hsCRP assay during the luteal phase, especially for moderate -severe endometriosis. At a cut-off level of hsCRP > 0.71 mg/L, moderate-severe stages were diagnosed with 80.7% sensitivity and 63.9% specificity during the luteal phase. Using a similar cut-off value for CRP analyzed by the classical method, moderate-severe endometriosis was diagnosed with lower sensitivity (67.7%, p = 0.06) and comparable specificity (63.9%).

Conclusions: The hsCRP assay was superior to the classical CRP assay for the detection of low CRP levels and for revealing subclinical inflammation in plasma of women with endometriosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ROC of hsCRP and CRP for prediction of moderate-severe endometriosis. A: In an overall analysis (all cycle phases combined). The AUC was significantly higher for hsCRP analysis than for classical CRP analysis for the diagnosis of moderate-severe endometriosis in an overall analysis (all cycle phases combined, p = 0.018). B: In a luteal cycle phase. The AUC values of hsCRP and CRP were not significantly different (p = 0.065). C: In a follicular cycle phase. The AUC was higher for hsCRP analysis than for classical CRP analysis with borderline significance (p = 0.047). D: In a menstrual cycle phase. The AUC values of hsCRP and CRP were not significantly different (p = 0.83).

Similar articles

Cited by

References

    1. Mihalyi A, Kyama CM, Simsa P, Debrock S, Mwenda JM, D'Hooghe TM. Role of immunologic and inflammatory factors in the development of endometriosis: indications for treatment strategies. Therapy. 2005;2:623–639. doi: 10.2217/14750708.2.4.623. - DOI
    1. D'Hooghe TM, Debrock S, Hill JA, Meuleman C. Endometriosis and subfertility: Is the relationship resolved? Semin Reprod Med. 2003;21:243–254. - PubMed
    1. Kyama CM, Debrock S, Mwenda JM, D'Hooghe TM. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol. 2003;123:1–9. - PMC - PubMed
    1. Matalliotakis IM, Goumenou AG, Koumantakis GE, Neonaki MA, Koumantakis EE, Dionyssopoulou E, Athanassakis I, Vassiliadis S. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol. 2003;3:81–89. doi: 10.1016/S1567-5769(02)00216-3. - DOI - PubMed
    1. Vigano P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clinical Obstet Gynaecl. 2004;18:177–200. doi: 10.1016/j.bpobgyn.2004.01.007. - DOI - PubMed

Publication types